Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

VirnetX Holding (VHC) Research & Development (2016 - 2025)

Historic Research & Development for VirnetX Holding (VHC) over the last 10 years, with Q3 2025 value amounting to $1.1 million.

  • VirnetX Holding's Research & Development fell 280.61% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 84.45%. This contributed to the annual value of $6.0 million for FY2024, which is 3783.59% down from last year.
  • VirnetX Holding's Research & Development amounted to $1.1 million in Q3 2025, which was down 280.61% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, VirnetX Holding's Research & Development peaked at $4.8 million during Q2 2023, and registered a low of $1.1 million during Q3 2025.
  • For the 5-year period, VirnetX Holding's Research & Development averaged around $1.7 million, with its median value being $1.2 million (2022).
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 27888.45% in 2023, then tumbled by 7427.97% in 2024.
  • Over the past 5 years, VirnetX Holding's Research & Development (Quarter) stood at $2.1 million in 2021, then increased by 27.44% to $2.7 million in 2022, then decreased by 12.41% to $2.4 million in 2023, then dropped by 0.04% to $2.4 million in 2024, then crashed by 51.79% to $1.1 million in 2025.
  • Its Research & Development was $1.1 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.3 million in Q1 2025.